Literature DB >> 7451357

BBM-928, a new antitumor antibiotic complex. I. Production, isolation, characterization and antitumor activity.

H Ohkuma, F Sakai, Y Nishiyama, M Ohbayashi, H Imanishi, M Konishi, T Miyaki, H Koshiyama, H Kawaguchi.   

Abstract

A complex of the antitumor antibiotic BBM-928 was produced by an actinomycete strain No. G455-101. Four components, BBM-928 A, B, C and D, were isolated in crystalline form and characterized. They were shown to be cyclic depsipeptide antibiotics containing a quinoline nucleus as the chromophore. BBM-928 A is a monoacetyl derivative of BBM-928 B and a diacetyl derivative of BBM-928 C. BBM-928 components exhibit antimicrobial activity against Gram-positive and acid-fast bacteria. BBM-928 A is highly active in mice against various experimental tumors including leukemia P388, leukemia L1210, melanoma B16, LEWIS lung carcinoma and sarcoma 180. BBM-928 B is less active than BBM-928 A, and BBM-928 C has no antitumor activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7451357     DOI: 10.7164/antibiotics.33.1087

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

1.  Sequence-specific binding of luzopeptin to DNA.

Authors:  K R Fox; H Davies; G R Adams; J Portugal; M J Waring
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

2.  Interaction of the antitumour antibiotic luzopeptin with the hexanucleotide duplex d(5'-GCATGC)2. One-dimensional and two-dimensional n.m.r. studies.

Authors:  M S Searle; J G Hall; W A Denny; L P Wakelin
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

3.  Intracellular DNA damage produced by a series of diacridines.

Authors:  I A Roos; L P Wakelin; S J Henry
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

4.  Korkormicins, novel depsipeptide antitumor antibiotics from Micromonospora sp C39500: fermentation, precursor directed biosynthesis and biological activities.

Authors:  K S Lam; D R Gustavson; G A Hesler; T T Dabrah; J A Matson; R L Berry; W C Rose; S Forenza
Journal:  J Ind Microbiol       Date:  1995-07

5.  1H- and 13C-n.m.r. studies of the antitumour antibiotic luzopeptin. Resonance assignments, conformation and flexibility in solution.

Authors:  M S Searle; J G Hall; P G Wakelin
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

Review 6.  Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.

Authors:  Javier Fernández; Laura Marín; Raquel Alvarez-Alonso; Saúl Redondo; Juan Carvajal; Germán Villamizar; Claudio J Villar; Felipe Lombó
Journal:  Mar Drugs       Date:  2014-05-09       Impact factor: 5.118

7.  New 3-Hydroxyquinaldic Acid Derivatives from Cultures of the Marine Derived Actinomycete Streptomyces cyaneofuscatus M-157.

Authors:  Francisco Javier Ortiz-López; Elsa Alcalde; Aida Sarmiento-Vizcaíno; Caridad Díaz; Bastien Cautain; Luis A García; Gloria Blanco; Fernando Reyes
Journal:  Mar Drugs       Date:  2018-10-08       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.